| Page 846 | Kisaco Research
 

Neil Inala

Chief Executive Officer
Nobias Therapeutics

Neil Inala

Chief Executive Officer
Nobias Therapeutics

Neil Inala

Chief Executive Officer
Nobias Therapeutics
 

Dane Corneil

AI Lead for Target-ID
Benevolentai

Dane Corneil

AI Lead for Target-ID
Benevolentai

Dane Corneil

AI Lead for Target-ID
Benevolentai
 

Andrew Hedin

Partner
Bessemer Venture Partners

Andrew Hedin

Partner
Bessemer Venture Partners

Andrew Hedin

Partner
Bessemer Venture Partners
 

Joel Dudley

Partner, Innovation
Endeavours

Joel Dudley

Partner, Innovation
Endeavours

Joel Dudley

Partner, Innovation
Endeavours
 

Daniel Jamieson

CEO
Biorelate

Daniel Jamieson

CEO
Biorelate

Daniel Jamieson

CEO
Biorelate
 

Ari Allyn-Feuer

Director, AI Product
GSK

Ari Allyn-Feuer

Director, AI Product
GSK

Ari Allyn-Feuer

Director, AI Product
GSK
 

Petrina Kamya

President & Global Head, AI Platforms
Insilico Medicine

Petrina Kamya

President & Global Head, AI Platforms
Insilico Medicine

Petrina Kamya

President & Global Head, AI Platforms
Insilico Medicine
 

Stephen MacKinnon

Vice President of Digital Chemistry
Recursion Pharma

Stephen MacKinnon

Vice President of Digital Chemistry
Recursion Pharma

Stephen MacKinnon

Vice President of Digital Chemistry
Recursion Pharma
 

Alex Gaither

Vice President and Head of Oncology
Exscientia

Alex Gaither

Vice President and Head of Oncology
Exscientia

Alex Gaither

Vice President and Head of Oncology
Exscientia
 

Michal Preminger

Head of Innovation
Johnson & Johnson

Michal Preminger

Head of Innovation
Johnson & Johnson

Michal Preminger

Head of Innovation
Johnson & Johnson